Genelux Corp
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Genelux Corp
Did you know?
Capital expenditures increased by 188% from FY24 to FY25.
Current Price
$2.85
+4.01%Profile
Valuation (TTM)
Market Cap$108.45M
P/E-3.37
EV—
P/B9.39
Shares Out38.05M
P/Sales—
Revenue$0.00
EV/EBITDA—
GNLX (GNLX) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for GNLX yet. Check back after the next earnings report.
← Back to GNLX overview